Related Experiment Video
Updated: Sep 3, 2025
09:06
Intra-lymph Node Injection of Biodegradable Polymer Particles
Published on: January 2, 2014
14.6K
Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes.
Zesheng Cheng1, Haiying Que1, Li Chen1
1Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatricts, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, China.
Pharmaceutics
|July 27, 2022
Summary
Nanotechnology and biomaterials are advancing lymph-node-targeted drug delivery for better disease treatment and vaccination. These lymph-node-targeted nanocarriers show promise for diagnostics and cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunology
Background:
- The lymphatic system is crucial for maintaining bodily fluid balance, metabolizing lipids, and regulating immune responses.
- Lymph nodes (LNs) are primary sites for cancer metastasis, significantly impacting patient prognosis.
- Targeted lymphatic delivery systems are essential for effective disease treatment and vaccination strategies.
Purpose of the Study:
- To review the physiological roles of lymph nodes (LNs).
- To explore the involvement of LNs in various diseases.
- To survey recent advancements in lymph-node-targeted drug delivery systems using nanotechnology and biomaterials.
Main Methods:
- Review of current literature on lymph node physiology and disease roles.
- Analysis of nanotechnologies and biomaterials for targeted drug delivery.
- Categorization of typical lymph-node-targeted nanomaterial-based systems.
Main Results:
- Nanomaterials like liposomes, micelles, inorganic nanoparticles, hydrogels, and nanocapsules are being developed for LN targeting.
- These systems mimic endogenous molecules for enhanced targeting efficiency.
- Lymph-node-targeted nanocarriers offer potential for improved disease diagnosis and cancer therapy.
Conclusions:
- Lymph-node-targeted drug delivery systems are a rapidly advancing field with significant therapeutic potential.
- Nanotechnology and biomaterials are key enablers for developing effective LN-targeted therapies.
- Future research should focus on optimizing these systems for clinical applications in disease treatment and vaccination.
